Liquid biopsies have become more common in cancer care, particularly for people with non-small cell lung cancer. But what are liquid biopsies, and how are they used? Learn more here about who might need a liquid biopsy and what to expect from the procedure.
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses what multi-cancer early detection tests are, the ongoing research being done around them, and their potential use as a future tool for multi-cancer screening.
In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, 2-time cancer survivor Mai Achong discusses the importance of listening to your body and advocating for yourself during cancer, managing fertility concerns, and finding support.
Cancer survivor Diane Mapes shares how recent changes to U.S. law means quicker delivery of test results for people diagnosed with cancer, why this direct access to medical reports can cause a different kind of “scanxiety,” and how to cope with uncertainty until you hear from your doctor.
Dr. H. Jack West shares what people with lung cancer should know about biomarker testing, including why it is important in planning treatment and what to expect during the testing process.
For people at high risk of developing skin cancer, doctors may recommend screening. Learn what to expect during a skin cancer screening and everyday ways to prevent skin cancer.
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses what “scanxiety” is, how it impacts people with cancer and survivors, and what they can do to cope.
Your doctor may recommend a fine needle aspiration biopsy, also called a fine needle biopsy or FNA, to find out if a mass from a scan or examination is cancer. Here, learn what the procedure is, how to prepare, and how it’s used to diagnose cancer.
A biopsy is a valuable procedure for diagnosing and treating cancer. But some people may worry that a biopsy could lead to the cancer spreading. In this post, we discuss how this idea started, and why the benefits of biopsies outweigh the risks.
In this Q&A, Dr. Jessica Geiger discusses a new ASCO guideline on the diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck.
